244 related articles for article (PubMed ID: 21316835)
1. Comment on 'Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)"'.
Mitrasinovic PM
Biophys Chem; 2011 Mar; 154(2-3):102. PubMed ID: 21316835
[No Abstract] [Full Text] [Related]
2. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S
Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807
[No Abstract] [Full Text] [Related]
3. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.
Park JW; Jo WH
J Chem Inf Model; 2009 Dec; 49(12):2735-41. PubMed ID: 19957991
[TBL] [Abstract][Full Text] [Related]
4. Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV).
Mihajlovic ML; Mitrasinovic PM
Biophys Chem; 2008 Aug; 136(2-3):152-8. PubMed ID: 18584938
[TBL] [Abstract][Full Text] [Related]
5. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S
Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747
[TBL] [Abstract][Full Text] [Related]
6. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
Du QS; Wang SQ; Chou KC
Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
[TBL] [Abstract][Full Text] [Related]
7. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.
Wang SQ; Du QS; Chou KC
Biochem Biophys Res Commun; 2007 Mar; 354(3):634-40. PubMed ID: 17266937
[TBL] [Abstract][Full Text] [Related]
8. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
Singh A; Soliman ME
Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
[TBL] [Abstract][Full Text] [Related]
9. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
Kar P; Knecht V
J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951
[TBL] [Abstract][Full Text] [Related]
10. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
11. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.
Karthick V; Ramanathan K
Cell Biochem Biophys; 2014 Mar; 68(2):291-9. PubMed ID: 23794010
[TBL] [Abstract][Full Text] [Related]
12. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.
Shu M; Lin Z; Zhang Y; Wu Y; Mei H; Jiang Y
J Mol Model; 2011 Mar; 17(3):587-92. PubMed ID: 20517627
[TBL] [Abstract][Full Text] [Related]
14. H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site.
Yusuf M; Mohamed N; Mohamad S; Janezic D; Damodaran KV; Wahab HA
J Chem Inf Model; 2016 Jan; 56(1):82-100. PubMed ID: 26703840
[TBL] [Abstract][Full Text] [Related]
15. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M
J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH
J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083
[No Abstract] [Full Text] [Related]
17. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
Hurt AC; Lowther S; Middleton D; Barr IG
Antiviral Res; 2010 Sep; 87(3):361-6. PubMed ID: 20603155
[TBL] [Abstract][Full Text] [Related]
18. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza.
Hill AW; Guralnick RP; Wilson MJ; Habib F; Janies D
Infect Genet Evol; 2009 Mar; 9(2):169-78. PubMed ID: 19022400
[TBL] [Abstract][Full Text] [Related]
19. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
Mitrasinovic PM
Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
[TBL] [Abstract][Full Text] [Related]
20. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
